Dose-dense taxotere (T) and adriamycin/cyclophosphamide (AC) as neoadjuvant treatment in locally advanced breast cancer (LABC).

被引:0
|
作者
García-Mata, J
Calvo, L
García-Palomo, A
Mel, JR
Almanza, MC
Ramos, M
de Paz, LH
机构
[1] H Santa Maria Nai, Orense, Spain
[2] H Juan Canalejo, La Coruna, Spain
[3] H Leon, Leon, Spain
[4] H Xeral Calde, Lugo, Spain
[5] Clin Povisa, Vigo, Spain
[6] Ctr Oncol, La Coruna, Spain
[7] H Arquitecto Marcide, Ferrol, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S226 / S227
页数:2
相关论文
共 50 条
  • [31] Docetaxel and epirubicin as neoadjuvant chemotherapy (CT) in locally advanced breast cancer (LABC).
    Alkhatib, F
    Alawadi, S
    Grohn, P
    Motawy, M
    Fayaz, S
    Patel, J
    Attia, N
    Trad, D
    Delvadia, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 21 - 22
  • [32] A Phase II Trial of Dose-Dense Neoadjuvant Gemcitabine, Epirubicin, and Albumin-Bound Paclitaxel With Pegfilgrastim in the Treatment of Patients With Locally Advanced Breast Cancer
    Yardley, Denise A.
    Zubkus, John
    Daniel, Brooke
    Inhorn, Roger
    Lane, Cassie M.
    Vazquez, Elizabeth R.
    Naot, Yuval
    Burris, Howard A., III
    Hainsworth, John D.
    [J]. CLINICAL BREAST CANCER, 2010, 10 (05) : 367 - 372
  • [33] THE CLINICAL OUTCOMES OF NEOADJUVANT DOSE-DENSE DOXORUBICIN-CISPLATIN CHEMOTHERAPY IN COMBINED TREATMENT OF LOCALLY-ADVANCED CERVICAL CANCER
    Smirnova, Olga
    Bondarev, Nikolay
    Ulrikh, Elena
    Mikaya, Nikolay
    Lavrinovich, Olga
    Petrova, Anna
    Meshkova, Irina
    Mischenko, Andrey
    Artemyeva, Anna
    Urmancheeva, Adel
    Berlev, Igor
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 252 - 252
  • [34] COMBINED TREATMENT FOR LOCALLY ADVANCED BREAST-CANCER (LABC)
    COLOZZA, M
    GORI, S
    BELSANTI, V
    MOSCONI, A
    ROSSETTI, R
    BASURTO, C
    ANASTASI, P
    LATINI, P
    MARANZANO, E
    CHECCAGLINI, F
    MERCATI, U
    TONATO, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (01) : 125 - 125
  • [35] Targeted inhibition of farnesyltransferase in locally advanced breast cancer: A phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide
    Sparano, Joseph A.
    Moulder, Stacy
    Kazi, Aslamuzzaman
    Vahdat, Linda
    Li, Tianhong
    Pellegrino, Christine
    Munster, Pam
    Malafa, Mokenge
    Lee, David
    Hoschander, Shira
    Hopkins, Una
    Hershman, Dawn
    Wright, John J.
    Sebti, Said M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3013 - 3018
  • [36] Motor dominant neuropathy induced by adjuvant therapy with adriamycin and cyclophosphamide followed by dose-dense paclitaxel in a breast cancer patient
    Hikino H.
    Kawashima M.
    Yamada T.
    Ozaki N.
    [J]. International Journal of Clinical Oncology, 2006, 11 (4) : 332 - 335
  • [37] Neoadjuvant weekly carboplatin and paclitaxel followed by dose dense adriamycin/cyclophosphamide in locally advanced triple negative breast cancer: A single-center real-world experience
    Chen, Nan
    Bulsara, Shaun
    Hilsenbeck, Susan
    Nangia, Julie
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [38] Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study
    Panici, Pierluigi Benedetti
    Palaia, Innocenza
    Marchetti, Claudia
    Ruscito, Ilary
    Fischetti, Margherita
    Musella, Angela
    Di Donato, Violante
    Perniola, Giorgia
    Vertechy, Laura
    Muzii, Ludovico
    [J]. ONCOLOGY, 2015, 89 (02) : 103 - 110
  • [39] Dose-dense chemotherapy as adjuvant treatment for breast cancer
    Atkins, CD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (04) : 749 - 750
  • [40] Additional metabolic effects at the neoadjuvant chemotherapy (NCT) of locally advanced breast cancer (LABC).
    Abramova, Natalya A.
    Vladimirova, Liubov Yu
    Shikhliarova, Alla I.
    Storozhakova, Anna E.
    Kova, Valeriya S. Myag
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)